BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Calypte Biomedical Corporation

Calypte Biomedical Corporation is dedicated to developing and marketing in vitro testing algorithms for improved diagnosis of HIV infection, STDs, and other chronic diseases. Calypte is a pioneer in the development of non-blood assays for HIV antibody determination, and is the first and only company to achieve USFDA approval of a urine-based HIV-1 antibody screening test and supplemental Western Blot. Following the success of the Calypte urine-based HIV-1 antibody testing algorithm used in laboratories, Calypte is now commercializing Aware™ rapid tests for the determination of HIV 1/2 antibodies in blood, urine, and oral fluid. Calypte has developed these three 20-minute tests to offer unrivalled testing flexibility in a non-laboratory setting. Realizing that no single approach to HIV testing will meet the needs of every testing environment, Calypte has developed three different testing solutions, at least one of which should be well suited to a given testing and counseling setting.


Contact Details:
5 Centerpointe Drive, Suite 400
Lake Oswego
OR
97035
United States of America
Tel:(1) 971-204-0282
Fax:(1) 971-204-0284
Email:customerservice@calypte.com
WWW:

www.calypte.com/




Loading...

Recent Publications by Calypte Biomedical Corporation:

Report of the Task Force on the future of OTC drugs.
OBJECTIVE: To evaluate the accuracy, utility, and cost effectiveness of a...
27th September, 2002
Calypte Biomedical, USA. Food Drug Law J. 2000;55(1):27-31.

BioNews Results for Calypte Biomedical Corporation:

Compounds that slow blood vessel growth may offer cancer treatment
NetIndia123.com:  Oct 5 2008 8:21AM Matching: biomedical
Can slowing down 'fat burning' genes reduce obesity?
NetIndia123.com:  Oct 5 2008 8:21AM Matching: biomedical
7th Annual Charlotte Biotechnology Conference to Feature Dr. Roger Newton, co-discoverer of Lipitor and Founde
Pharma Live:  Oct 5 2008 7:49AM Matching: biomedical
Human Proteins That Stop Cancer Cell Growth Identified
MedIndia:  Oct 5 2008 6:05AM Matching: biomedical
Compounds that slow blood vessel growth may offer cancer treatment
Webindia123:  Oct 4 2008 9:37PM Matching: biomedical
Promote your company here: BioNewsCast - Press Release Distribution

View more Calypte Biomedical Corporation news.

Calypte Biomedical Corporation (CBMC.OB) Financial information Links from Barchart

CBMC.OB Quote from from Barchart.com
CBMC.OB Chart from from Barchart.com
CBMC.OB Profile from from Barchart.com
CBMC.OB Opinion from from Barchart.com

View more Calypte Biomedical Corporation finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 205 times since April 2007, the link to the organisation's website has been followed 33 times

Recent Search Terms used to find this page: Calypte | calypte biomedical | aware hiv oral test calypte 2007 | .

Search for more companies in Lake Oswego

Search for more companies in OR



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Calypte Biomedical Corporation
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.